Impact of systemic treatments on the course of HLA-B27-associated uveitis: A retrospective study of 101 patients.

Nabil Bouzid Yvan JamillouxRoland ChapurlatPierre PradatAudrey De ParisotLaurent KodjikianPascal Sève

Published in: PloS one (2020)

We report an open-label strategy to prevent the recurrences of HLA-B27-associated AU. First-line sulfasalazine reduced uveitis relapses. The use of anti-TNFα agents for ophthalmologic purposes was unnecessary with rare exceptions.

Keyphrases

end stage renal disease
juvenile idiopathic arthritis
ejection fraction
newly diagnosed
chronic kidney disease
rheumatoid arthritis
peritoneal dialysis
gold nanoparticles
patient reported
disease activity
quantum dots